华蟾素注射液（Ｉｎｊｅｃｔｉｏｃｉｎｏｂｕｆａｃｉｎｉ）是中华大蟾蜍皮的水制剂，动物实验表明，对动物移植性肿瘤抑制率为３０．４％～６３．７％［１］，我们自１９９３年４月～１９９８年７月用华蟾素注射液治疗不能施以手术的食管癌、贲门癌共２８例中、晚期患者，现? Injectiocinobufacini (Injectiocinobufacini) is an aqueous preparation of Chinese giant molt. Animal experiments showed that the inhibitory rate of transplanted tumors in animals was 30.4% to 63.7% [1]. We have been operating since April 1993 to 1998. In July, a total of 28 patients with esophageal or cardiac cancer who could not undergo surgery were treated with Huachansu injection.